Mesa Laboratories, Inc.
MLAB
$105.48
-$1.87-1.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 249.13M | 247.54M | 245.26M | 242.35M | 240.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 249.13M | 247.54M | 245.26M | 242.35M | 240.98M |
| Cost of Revenue | 90.86M | 93.06M | 92.82M | 91.34M | 88.88M |
| Gross Profit | 158.27M | 154.48M | 152.44M | 151.01M | 152.10M |
| SG&A Expenses | 119.45M | 117.09M | 117.22M | 116.97M | 115.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 230.62M | 230.31M | 230.22M | 228.08M | 223.41M |
| Operating Income | 18.51M | 17.23M | 15.04M | 14.27M | 17.57M |
| Income Before Tax | 12.01M | 14.07M | 7.26M | 9.07M | 5.96M |
| Income Tax Expenses | 5.30M | 10.33M | 8.83M | 9.69M | 7.94M |
| Earnings from Continuing Operations | 6.71 | 3.73 | -1.57 | -0.62 | -1.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.71M | 3.73M | -1.57M | -620.00K | -1.97M |
| EBIT | 18.51M | 17.23M | 15.04M | 14.27M | 17.57M |
| EBITDA | 41.78M | 42.25M | 39.84M | 39.29M | 42.10M |
| EPS Basic | 1.23 | 0.67 | -0.30 | -0.12 | -0.36 |
| Normalized Basic EPS | 1.37 | 1.60 | 0.83 | 1.09 | 0.50 |
| EPS Diluted | 1.20 | 0.64 | -0.32 | -0.14 | -0.37 |
| Normalized Diluted EPS | 1.35 | 1.58 | 0.81 | 1.07 | 0.49 |
| Average Basic Shares Outstanding | 22.05M | 21.95M | 21.85M | 21.75M | 21.68M |
| Average Diluted Shares Outstanding | 22.20M | 22.09M | 21.96M | 21.89M | 21.76M |
| Dividend Per Share | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Payout Ratio | 52.49% | 93.97% | -222.26% | -560.97% | -175.68% |